BRKR - Bruker - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1167941087
Scientific Instruments, Analytical Solutions, Diagnostic Tools, X-ray Instruments
Bruker Corporation is a leading provider of scientific instruments and analytical solutions that cater to a wide range of industries, including life sciences, pharmaceuticals, and materials research. With a global presence, the company operates through four segments, each focusing on a specific area of expertise.
The Bruker Scientific Instruments (BSI) segment is divided into three sub-segments: BioSpin, CALID, and Nano. BioSpin focuses on life science tools and single and multiple modality systems, while CALID specializes in life science mass spectrometry and related products. The Nano segment, on the other hand, offers a range of analytical and process analysis instruments and solutions.
In addition to its life science offerings, Bruker Corporation also provides a range of portable analytical and bioanalytical detection systems, including X-ray instruments, analytical tools for electron microscopes, and handheld, portable, and mobile X-ray fluorescence spectrometry instruments. The company's atomic force microscopy instrumentation and non-contact nanometer resolution solution topography solutions are also highly regarded in the industry.
Bruker Corporation has been at the forefront of COVID-19 research, offering SARS-CoV-2 testing solutions for the diagnosis of COVID-19 infection, as well as Fluorotyper-SARS-CoV-2 plus kits. The company's advanced optical fluorescence microscopy instruments and products and services supporting multi-omics research have also been instrumental in advancing our understanding of the virus.
The company's superconducting materials and devices, including metallic low temperature superconductors, are used in a variety of applications, from medical devices to industrial equipment. Bruker Corporation's non-superconducting high technology tools, such as synchrotron and beamline instrumentation, are also highly sought after by researchers and industries alike.
Headquartered in Billerica, Massachusetts, Bruker Corporation was incorporated in 1991 and has since established itself as a leader in the scientific instruments and analytical solutions market. With a strong commitment to innovation and customer satisfaction, the company continues to push the boundaries of scientific discovery and advancement.
For more information, please visit the company's website at https://www.bruker.com.
Drawdown (Underwater) Chart
![Drawdown / Underwater Chart for BRKR - Bruker - Stock Price & Dividends](https://www.valueray.com/images/drawdown_chart/BRKR.NASDAQ_drawdown.png)
Overall Trend and Yearly Seasonality
![Drawdown / Underwater Chart for BRKR - Bruker - Stock Price & Dividends](https://www.valueray.com/images/chart/BRKR.NASDAQ_seasonality.png)
BRKR Stock Overview
Market Cap in USD | 9,462m |
Sector | Healthcare |
Industry | Medical Devices |
GiC SubIndustry | Life Sciences Tools & Services |
TER | 0.00% |
IPO / Inception | 2000-08-04 |
BRKR Stock Ratings
Growth 5y | 29.1 |
Fundamental | 42.8 |
Dividend | 46.7 |
Rel. Performance vs Sector | -2.03 |
Analysts | 4.18/5 |
Fair Price Momentum | 67.01 USD |
Fair Price DCF | 31.55 USD |
BRKR Dividends
Dividend Yield 12m | 0.31% |
Yield on Cost 5y | 0.42% |
Dividends CAGR 5y | 4.56% |
Payout Consistency | 98.0% |
BRKR Growth Ratios
Growth 12m | -7.81% |
Growth Correlation 12m | 23% |
Growth Correlation 3m | -61% |
CAGR 5y | 6.05% |
CAGR/Mean DD 5y | 0.33 |
Sharpe Ratio 12m | -0.37 |
Alpha vs SP500 12m | -31.64 |
Beta vs SP500 5y weekly | 1.21 |
ValueRay RSI | 60.36 |
Volatility GJR Garch 1y | 37.67% |
Price / SMA 50 | -3.69% |
Price / SMA 200 | -11.37% |
Current Volume | 1007.1k |
Average Volume 20d | 1012.4k |
External Links for BRKR Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of July 27, 2024, the stock is trading at USD 64.23 with a total of 1,007,084 shares traded.
Over the past week, the price has changed by +2.74%, over one month by -1.08%, over three months by -20.24% and over the past year by -6.85%.
According to ValueRays Forecast Model, BRKR Bruker will be worth about 74.3 in July 2025. The stock is currently trading at 64.23. This means that the stock has a potential upside of +15.6%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 77.9 | 21.3 |
Analysts Target Price | 77.8 | 21.1 |
ValueRay Target Price | 74.3 | 15.6 |